These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

55 related articles for article (PubMed ID: 1702687)

  • 1. [Use of myelin basic protein in neurology].
    Fang J
    Zhonghua Yi Xue Za Zhi; 1990 Oct; 70(10):595-7. PubMed ID: 1702687
    [No Abstract]   [Full Text] [Related]  

  • 2. Suppression of experimental autoimmune encephalomyelitis by oral administration of myelin antigens: IV. Suppression of chronic relapsing disease in the Lewis rat and strain 13 guinea pig.
    Brod SA; al-Sabbagh A; Sobel RA; Hafler DA; Weiner HL
    Ann Neurol; 1991 Jun; 29(6):615-22. PubMed ID: 1716432
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Myelin proteolipid protein: an effective autoantigen and target of autoimmunity in multiple sclerosis.
    Greer JM; Pender MP
    J Autoimmun; 2008 Nov; 31(3):281-7. PubMed ID: 18502611
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Myelin basic protein, a specific protein of the central nervous system.
    Karcher D
    Bull Soc Belge Ophtalmol; 1983 Nov; 208 Pt 1():85-7. PubMed ID: 6202352
    [No Abstract]   [Full Text] [Related]  

  • 5. Modifications of myelin basic protein in DM20 transgenic mice are similar to those in myelin basic protein from multiple sclerosis.
    Mastronardi FG; Mak B; Ackerley CA; Roots BI; Moscarello MA
    J Clin Invest; 1996 Jan; 97(2):349-58. PubMed ID: 8567954
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Suppression of experimental autoimmune encephalomyelitis by selective blockade of encephalitogenic T-cell infiltration of the central nervous system.
    Yan SS; Wu ZY; Zhang HP; Furtado G; Chen X; Yan SF; Schmidt AM; Brown C; Stern A; LaFaille J; Chess L; Stern DM; Jiang H
    Nat Med; 2003 Mar; 9(3):287-93. PubMed ID: 12598893
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Conclusion: is myelin basic protein the right antigen and experimental allergic encephalomyelitis the right model for multiple sclerosis?
    Alvord EC
    Prog Clin Biol Res; 1984; 146():503-8. PubMed ID: 6201920
    [No Abstract]   [Full Text] [Related]  

  • 8. Induction of oligodendrocyte proliferation and remyelination after chronic demyelination. Relevance to multiple sclerosis.
    Raine CS; Moore GR; Hintzen R; Traugott U
    Lab Invest; 1988 Oct; 59(4):467-76. PubMed ID: 2459499
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Phospholipids in demyelinating diseases.
    Bukovský V; Dobrota D; Mézesová V
    Acta Univ Carol Med (Praha); 1987; 33(7-8):561-9. PubMed ID: 3455640
    [No Abstract]   [Full Text] [Related]  

  • 10. [Toxic nervous pathology: biochemistry of myelin and demyelinizing conditions].
    Baumann N
    Eur J Toxicol; 1972; 5(1):7-11. PubMed ID: 4647427
    [No Abstract]   [Full Text] [Related]  

  • 11. Serum antimyelin factors in experimental allergic encephalomyelitis and multiple sclerosis.
    Seil FJ; Agrawal HC
    Prog Clin Biol Res; 1984; 146():199-206. PubMed ID: 6201891
    [No Abstract]   [Full Text] [Related]  

  • 12. Intrathecal administration of neutralizing antibody against Fas ligand suppresses the progression of experimental autoimmune encephalomyelitis.
    Okuda Y; Sakoda S; Fujimura H; Nagata S; Yanagihara T; Bernard CC
    Biochem Biophys Res Commun; 2000 Aug; 275(1):164-8. PubMed ID: 10944459
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intravenous antigen administration as a therapy for autoimmune demyelinating disease.
    Racke MK; Critchfield JM; Quigley L; Cannella B; Raine CS; McFarland HF; Lenardo MJ
    Ann Neurol; 1996 Jan; 39(1):46-56. PubMed ID: 8572666
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Enzymatic degradation of myelin basic protein in central nervous system lesions of monkeys with experimental allergic encephalomyelitis.
    Rauch HC; Einstein ER; Csejtey J
    Neurobiology; 1973; 3(3):195-205. PubMed ID: 4124846
    [No Abstract]   [Full Text] [Related]  

  • 15. Experimental autoimmune encephalomyelitis: the antigen specificity of T lymphocytes determines the topography of lesions in the central and peripheral nervous system.
    Berger T; Weerth S; Kojima K; Linington C; Wekerle H; Lassmann H
    Lab Invest; 1997 Mar; 76(3):355-64. PubMed ID: 9121118
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Myelin proteins and demyelinating disease (author's transl)].
    Uyemura K; Kitamura K; Yamanaka T
    Tanpakushitsu Kakusan Koso; 1974 Oct; 19(11):1018-32. PubMed ID: 4140549
    [No Abstract]   [Full Text] [Related]  

  • 17. Molecular "negativity" may underlie multiple sclerosis: role of the myelin basic protein family in the pathogenesis of MS.
    Musse AA; Harauz G
    Int Rev Neurobiol; 2007; 79():149-72. PubMed ID: 17531841
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chronic relapsing necrotizing encephalomyelitis produced by myelin basic protein in mice.
    Moore GR; McCarron RM; McFarlin DE; Raine CS
    Lab Invest; 1987 Aug; 57(2):157-67. PubMed ID: 2441138
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reversal of acute experimental autoimmune encephalomyelitis and prevention of relapses by treatment with a myelin basic protein peptide analogue modified to form long-lived peptide-MHC complexes.
    Samson MF; Smilek DE
    J Immunol; 1995 Sep; 155(5):2737-46. PubMed ID: 7544383
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Glucocorticoids in multiple sclerosis and experimental autoimmune encephalomyelitis.
    Reichardt HM; Gold R; Lühder F
    Expert Rev Neurother; 2006 Nov; 6(11):1657-70. PubMed ID: 17144780
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.